HexemBio is a biotechnology company developing regenerative therapies based on its Synthetic Human Yolk Sac technology, designed to rejuvenate aging blood stem cells. The company launched in 2026 with a $10.4M seed round led by Draper Associates. It aims to create the first scalable and reproducible rejuvenation therapy targeting early developmental cell states.

InnSight Technology, Inc. is a biotechnology company developing tear fluid analytics for non-invasive disease detection. Its platform collects and analyzes tear fluid to enable detection of hard-to-diagnose diseases.

Visionaire Products, Inc. is a Pittsburgh, Pennsylvania-based biotechnology company dedicated to improving patient outcomes through novel ocular health devices. It is developing a device for ocular fluid biopsy and has received SBIR awards totaling over $1.25 million to support its research.